US 11,980,388 B2
Cellulite treatment apparatus
Jonathan Podmore, San Carlos, CA (US); Earl Bright, II, Sunnyvale, CA (US); Arthur Ferdinand, Gilroy, CA (US); Joshua Makower, Los Altos Hills, CA (US); Pablo Acosta, Newark, CA (US); and John Hanley, Manhattan Beach, CA (US)
Assigned to Revelle Aesthetics, Inc., Mountain View, CA (US)
Filed by REVELLE AESTHETICS, INC., Mountain View, CA (US)
Filed on Aug. 17, 2023, as Appl. No. 18/234,990.
Application 18/234,990 is a continuation of application No. 17/687,370, filed on Mar. 4, 2022.
Application 17/687,370 is a continuation in part of application No. 17/154,232, filed on Jan. 21, 2021.
Application 17/687,370 is a continuation of application No. PCT/US2020/049590, filed on Sep. 5, 2020.
Application 17/154,232 is a continuation in part of application No. PCT/US2019/042871, filed on Jul. 22, 2019.
Claims priority of provisional application 63/049,705, filed on Jul. 9, 2020.
Claims priority of provisional application 62/911,111, filed on Oct. 4, 2019.
Claims priority of provisional application 62/896,676, filed on Sep. 6, 2019.
Claims priority of provisional application 62/825,447, filed on Mar. 28, 2019.
Claims priority of provisional application 62/802,368, filed on Feb. 7, 2019.
Claims priority of provisional application 62/798,515, filed on Jan. 30, 2019.
Claims priority of provisional application 62/736,016, filed on Sep. 25, 2018.
Claims priority of provisional application 62/702,314, filed on Jul. 23, 2018.
Prior Publication US 2023/0389956 A1, Dec. 7, 2023
Int. Cl. A61B 17/3209 (2006.01); A61B 17/00 (2006.01); A61B 17/3201 (2006.01); A61B 17/3211 (2006.01); A61N 5/06 (2006.01)
CPC A61B 17/32093 (2013.01) [A61B 17/3201 (2013.01); A61B 17/3211 (2013.01); A61N 5/0616 (2013.01); A61B 2017/00761 (2013.01); A61B 2017/32113 (2013.01); A61N 2005/063 (2013.01); A61N 2005/0651 (2013.01)] 10 Claims
OG exemplary drawing
 
1. A cellulite treatment apparatus for treating expressions of cellulite on a patient's skin associated with a septa treatment site, comprising:
a handle;
a shaft longitudinally extending from the handle, the shaft sized and shaped to be inserted within tissue and to be advanced to the septa treatment site without assistance from tissue stabilizing structure applied to the patient's skin;
a septa engaging assembly at a distal portion of the shaft, the septa engaging assembly comprises a first link rotatably attached to a second link at a pivot, and a drive shaft attached to the first link, the first link, second link and drive shaft being configurable within the shaft, wherein manipulation of the drive shaft causes the first link and second link to project laterally from the shaft; and
an actuator on the handle to actuate the septa engaging assembly, wherein the actuator positions the septa engaging assembly in at least a retracted position, a septa tensioning position and a septa disruption position;
wherein the first link is configured to function as a blocker of a portion of the second link when the first link is substantially aligned with the second link and the second link includes a beveled protrusion that extends proximally from the pivot when the first link and second link project laterally from the shaft.